Trade issues with China H.R. 1, American Recovery and Reinvestment Act of 2009, as it relates to the taxation of foreign earnings of U.S. multinational corporations.
H. Con. Res. 85 and S. Con. Res. 13, setting forth the congressional budget for the U.S. Governoment for FY 2010, as it relates to the taxation for foreign earnings of U.S. multinational corporations.
Issues related to the taxation of foreign earnings of U.S. multinational corporations S.515/H.R. 1260:  Patent Reform Act of 2009 H.R. 6331 (110th Congress): To amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare Program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes.  In particular, execution of the kidney education and bundling provisions. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. 
H.R.1:  The American Recovery and Reinvestment Act (stimulus bill); Specifically focused on aspects of the bill related to 
comparative effectiveness research.
H.R.1548 : To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes.
S.547 : A bill to amend title XIX of the Social Security Act to reduce the costs of prescription drugs for enrollees of Medicaid managed care organizations by extending the discounts offered under fee-for-service Medicaid to such organizations. 
H.R.1765 : To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program. 
H.R.1085/S. 442: To impose a limitation on lifetime aggregate limits imposed by health plans
Drug and device marketing and promotion
Drug and biological product pricing and reimbursement
Healthcare-acquired infections
Issues regarding 340B
Lifetime caps for insurance
Medical product safety
Prescription drug pedigree and anti-counterfeiting policy H.R.1:  The American Recovery and Reinvestment Act (stimulus bill); Specifically focused on aspects of the bill related to comparative effectiveness research.
H.R.1548 : To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes. S. 301: A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP
S.547 : A bill to amend title XIX of the Social Security Act to reduce the costs of prescription drugs for enrollees of Medicaid managed care organizations by extending the discounts offered under fee-for-service Medicaid to such organizations. 
H.R.1765 : To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program. 
H.R.1085/S. 442: To impose a limitation on lifetime aggregate limits imposed by health plans. 
Drug and biological product pricing and reimbursement
Product Payment Issues
Therapy Payment Issues H.R. 1409/S. 560:  To amend the National Labor Relations Act to establish an efficient system to enable employees to form, join, or assist labor organizations, to provide for mandatory injunctions for unfair labor practices during the organizing efforts, and for other purposes
TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid LBR - Labor Issues/Antitrust/Workplace
34 - Health & Human Services, Dept of (HHS) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 39 - State, Dept of (DOS) 34 - Health & Human Services, Dept of (HHS) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 39 - State, Dept of (DOS) 34 - Health & Human Services, Dept of (HHS) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 39 - State, Dept of (DOS) 34 - Health & Human Services, Dept of (HHS) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 39 - State, Dept of (DOS) 34 - Health & Human Services, Dept of (HHS) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 39 - State, Dept of (DOS) 34 - Health & Human Services, Dept of (HHS) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 39 - State, Dept of (DOS)
BAXTER HEALTHCARE CORPORATION
1501 K STREET, NW, SUITE 375, WASHINGTON, DC, 20006, US
JOSEPH V SCHWAN (Deputy Chief of Staff, U.S. Dept of Commerce) JOSEPH V SCHWAN (Deputy Chief of Staff, U.S. Dept of Commerce) JOSEPH V SCHWAN (Deputy Chief of Staff, U.S. Dept of Commerce) SARAH CREVISTON JED PERRY JOSEPH V SCHWAN (Deputy Chief of Staff, U.S. Dept of Commerce) SARAH CREVISTON JACK MANIKO (Counsel, House Cmte on Energy & Commerce) KELLI MILLS LESTER JED PERRY DEBORAH WILLIAMS (Prof. Staff, House Committee on Ways & Means) JOSEPH V SCHWAN (Deputy Chief of Staff, U.S. Dept of Commerce) SARAH CREVISTON JACK MANIKO (Counsel, House Cmte on Energy & Commerce) KELLI MILLS LESTER JED PERRY DEBORAH WILLIAMS (Prof. Staff, House Committe on Ways & Means) JOSEPH V SCHWAN (Deputy Chief of Staff, U.S. Dept of Commerce)
Deputy Chief of Staff, U.S. Dept of Commerce Deputy Chief of Staff, U.S. Dept of Commerce Deputy Chief of Staff, U.S. Dept of Commerce Deputy Chief of Staff, U.S. Dept of Commerce Counsel, House Cmte on Energy & Commerce Prof. Staff, House Committee on Ways & Means Deputy Chief of Staff, U.S. Dept of Commerce Counsel, House Cmte on Energy & Commerce Prof. Staff, House Committe on Ways & Means Deputy Chief of Staff, U.S. Dept of Commerce